A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cumberland Pharmaceuticals
• Treatments: Conivaptan

Criteria

Inclusion Criteria:

• Subject has a serum sodium value between 115 and 133 mEq/L

• Subject is euvolemic or hypervolemic

Exclusion Criteria:

• Clinical evidence of volume depletion or dehydration

• Uncontrolled brady- or tachyarrhythmias requiring emergent pacemaker placement or treatment